M. David

发表

Contrasting analytical and data-driven frameworks for radiogenomic modeling of normal tissue toxicities in prostate cancer.

Issam El Naqa, Luis Souhami, James Coates, 2015, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Ultrasound-based image guided radiotherapy for prostate cancer: comparison of cross-modality and intramodality methods for daily localization during external beam radiotherapy.

Frank Verhaegen, Tony Falco, Luis Souhami, 2006, International journal of radiation oncology, biology, physics.

Hypofractionated radiotherapy for favorable risk prostate cancer.

G. Shenouda, L. Souhami, S. Faria, 2010, International journal of radiation oncology, biology, physics.

Hypofractionated radiation therapy (66 Gy in 22 fractions at 3 Gy per fraction) for favorable-risk prostate cancer: long-term outcomes.

G. Shenouda, L. Souhami, S. Faria, 2013, International journal of radiation oncology, biology, physics.

Biochemical failure as single abnormality in patients with prostate cancer following radical treatment with external radiotherapy: follow-up without immediate treatment.

G. Shenouda, F. Deblois, C. Freeman, 2004, International braz j urol : official journal of the Brazilian Society of Urology.

Ductal carcinoma in situ--the influence of the radiotherapy boost on local control.

C. Freeman, M. David, M. Duclos, 2012, International journal of radiation oncology, biology, physics.

Radiomics-based machine learning models to distinguish between metastatic and healthy bone using lesion-center-based geometric regions of interest

J. Kildea, S. Skamene, M. David, 2022, Scientific Reports.

Intermittent androgen ablation in patients with biochemical failure after pelvic radiotherapy for localized prostate cancer.

G. Shenouda, B. Gagnon, C. Freeman, 2006, International journal of radiation oncology, biology, physics.

Silver clear nylon dressing is effective in preventing radiation-induced dermatitis in patients with lower gastrointestinal cancer: results from a phase III study.

C. Marijnen, T. Vuong, B. Cummings, 2011, International journal of radiation oncology, biology, physics.

Survival and Recurrence Patterns after Neoadjuvant Docetaxel, Cisplatin, and 5-Fluorouracil (DCF) for Locally Advanced Esophagogastric Adenocarcinoma

T. Alcindor, L. Ferri, M. David, 2014, Annals of Surgical Oncology.

Prostate-specific antigen bounce after high-dose-rate prostate brachytherapy and hypofractionated external beam radiotherapy.

A. Aprikian, L. Souhami, S. Faria, 2014, Brachytherapy.

A Clinical Screening Cooperative Group phase II evaluation of lobaplatin (ASTA D-19466) in advanced head and neck cancer

J. Armand, M. David, H. Roché, 2004, Investigational New Drugs.

The safety and usefulness of high-dose-rate endoluminal brachytherapy as a boost in the treatment of patients with esophageal cancer with external beam radiation with or without chemotherapy.

T. Vuong, S. Devic, M. Evans, 2005, International journal of radiation oncology, biology, physics.

Relative Sensitivity of Different Tests in the Detection of Low Titer Lupus Anticoagulants

C. Infante-Rivard, G. Rivard, J. Rauch, 1988, Thrombosis and Haemostasis.

External beam accelerated partial breast irradiation versus whole breast irradiation after breast conserving surgery in women with ductal carcinoma in situ and node-negative breast cancer (RAPID): a randomised controlled trial

Do-Hoon Kim, R. Vandermeer, T. Whelan, 2019, The Lancet.

What is the optimal management of dysphagia in metastatic esophageal cancer?

T. Alcindor, L. Ferri, S. Mayrand, 2012, Current oncology.

Is There a Detrimental Effect of Waiting for Radiotherapy for Patients With Localized Prostate Cancer?

Carolyn R. Freeman, Luis Souhami, G. Shenouda, 2006, American journal of clinical oncology.

No immediate treatment after biochemical failure in patients with prostate cancer treated by external beam radiotherapy.

G. Shenouda, C. Freeman, L. Souhami, 2006, Urology.

Treating intermediate-risk prostate cancer with hypofractionated external beam radiotherapy alone.

C. Freeman, A. Dal Pra, L. Souhami, 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Single-fraction high-dose-rate brachytherapy and hypofractionated external beam radiation therapy in the treatment of intermediate-risk prostate cancer - long term results.

H. Patrocinio, G. Shenouda, W. Kassouf, 2012, International journal of radiation oncology, biology, physics.

Enrollment of esophago-gastric cancer patients in a clinical fast-track program and it’s affect on time to treatment and quality of life.

T. Alcindor, J. Ramirez-Garcialuna, J. Spicer, 2018 .

Single fraction high-dose-rate brachytherapy and hypofractionated external beam radiation therapy in the treatment of intermediate-risk prostate cancer: Long-term results.

H. Patrocinio, G. Shenouda, W. Kassouf, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Scanned focussed ultrasound hyperthermia: Clinical response evaluation

K. Hynynen, R. Roemer, P. Harari, 1990 .

Comparison of bat system and a new 3D trans-abdominal ultrasound-based image-guided system for prostate daily localization during external beam radiotherapy

Tony Falco, Luis Souhami, R. Corns, 2004 .

Clinical Significance of Incidental Pulmonary Nodules in Esophageal Cancer Patients

A. Madani, D. Mulder, T. Alcindor, 2014, Journal of Gastrointestinal Surgery.